Kevin Mcnamara Sells 2,000 Shares of Chemed (NYSE:CHE) Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total value of $806,360.00. Following the sale, the chief executive officer owned 93,719 shares of the company’s stock, valued at approximately $37,785,626.42. This represents a 2.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Chemed Stock Up 0.6%

Shares of CHE opened at $402.03 on Friday. The business’s fifty day moving average is $441.48 and its 200 day moving average is $440.92. Chemed Corporation has a 12-month low of $385.00 and a 12-month high of $623.60. The stock has a market cap of $5.54 billion, a P/E ratio of 21.89, a P/E/G ratio of 1.59 and a beta of 0.46.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). Chemed had a net margin of 10.48% and a return on equity of 25.66%. The business had revenue of $639.34 million for the quarter, compared to the consensus estimate of $659.09 million. During the same quarter last year, the firm posted $6.83 EPS. The business’s revenue for the quarter was down .1% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, analysts expect that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, February 23rd. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s payout ratio is presently 13.06%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Oppenheimer decreased their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Zacks Research downgraded Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 4th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Chemed has a consensus rating of “Hold” and an average price target of $498.00.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Monetary Solutions Ltd bought a new position in shares of Chemed during the 4th quarter worth approximately $25,000. Los Angeles Capital Management LLC purchased a new position in shares of Chemed in the 4th quarter worth approximately $26,000. Smartleaf Asset Management LLC grew its holdings in shares of Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after acquiring an additional 25 shares in the last quarter. BOK Financial Private Wealth Inc. purchased a new stake in shares of Chemed during the fourth quarter valued at approximately $27,000. Finally, First Horizon Corp purchased a new stake in shares of Chemed during the third quarter valued at approximately $31,000. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.